English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduCan exercise, intermittent fasting and other lifestyle changes help patients with advanced breast cancer better tolerate side effects from treatment? A new $4-million NCI-funded study at Sylvester Comprehensive Cancer Center seeks to answer that question.
Tag: Breast Cancer Treatment
Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs 69
Age-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new analysis of more than 500,000 patient records. Patients aged 70 were nearly twice as likely to be passed over for standard-of-care radiation as those aged 69. There were no similar gaps between other age pairs. The study is among the first to demonstrate an age cutoff heuristic in oncology.
JNCCN: Mismatch in Breast Cancer Trial Results and Real-World Outcomes Based on Treatment Discontinuation
New population study in JNCCN on adjuvant hormone therapy for breast cancer finds correlation between hot flashes and poorer outcomes—in contrast to clinical trial results; likely due to patients with side-effects ending treatment early.
A Consensus View: Proton Therapy for Breast Cancer
Bruce Haffty, MD, MS, chair of Radiation Oncology and associate vice chancellor for Cancer Programs at Rutgers Cancer Institute of New Jersey, shares insight on proton therapy, a unique type of radiation treatment, for breast cancer.
Rutgers Cancer Institute of New Jersey Expert Available for Comment on Proton Therapy for Breast Cancer
New Brunswick, N.J., August 23, 2021 – Proton therapy is a type of radiation therapy treatment that targets a tumor in a very precise way, emerging as a unique modality for breast cancer due to the ability to minimize exposure surrounding healthy…
The Future of Breast Cancer Care is Here
Breast cancer care has changed in a myriad of ways thanks to advances in research, targeted therapies, and more personalized approaches to treatment. Rutgers Cancer Institute breast expert shares more about how the future of breast cancer care is here.
Phase 1 human trials suggest UIC-developed breast cancer drug is safe, effective
A new type of breast cancer drug can help halt progression of disease and is not toxic, according to phase 1 clinical trials.
App Detects Harsh Side Effect of Breast Cancer Treatment
Many breast cancer survivors suffer from lymph collection known as lymphedema. It causes arms to swell, and sufferers often become severely depressed. A new app detects it early, and its makers hope it will help spread awareness of the disease.